ATHE - ALTERITY THERAPEUTICS LTD
3.62
0.070 1.934%
Share volume: 9,842
Last Updated: 03-10-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.17%
PREVIOUS CLOSE
CHG
CHG%
$3.55
0.07
0.02%
Summary score
31%
Profitability
0%
Dept financing
18%
Liquidity
50%
Performance
60%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
-43.55%
Debt ratio change over timeo
0%
Current Ratio
3.54%
Quick Ratio
0%
Cash Position Ratio
2.35%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
-43.55%
Debt ratio change over timeo
0%
Current Ratio
3.54%
Quick Ratio
0%
Cash Position Ratio
2.35%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
-43.55%
Debt ratio change over time
0%
Current Ratio
3.54%
Quick Ratio
0%
Cash Position Ratio
2.35%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ATHE | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 0% | 18.86% | 8.19% | 13.03% |
| Return on assets | 0% | 4.09% | 3.09% | 2.33% |
| Return on sales | 0% | 27.43% | 25.26% | 28.06% |
| Return on invested capital | 0% | 8.62% | 7.99% | 2.07% |
| Profitability | 0% | 99% | 75% | 63% |
| Total debt ratio | -43.55% | 82.89% | 60.02% | 90.46% |
| Debt ratio change over time | 0% | -9.8% | -36.79% | 456.38% |
| Dept financing | 0% | 23% | 17% | 50% |
| Current Ratio | 3.54% | 1.12% | 1.16% | 0.91% |
| Quick Ratio | 0% | 0.86% | 0.92% | 0.8% |
| Cash Position Ratio | 2.35% | 0.12% | 0.51% | 0.36% |
| Liquididy | 50% | 33% | 40% | 29% |
| Short-term ratios | ATHE | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 0% | 7.71% | 21.69% | 0% |
| Return on assets | 0% | 4.46% | 2.98% | 1.66% |
| Return on sales | 0% | 29.24% | 25.4% | 23.5% |
| Return on invested capital | 0% | 5.83% | 22.48% | 0% |
| Profitability | 0% | 65% | 88% | 29% |
| Total debt ratio | -43.55% | 80.89% | 59.04% | 92.14% |
| Debt ratio change over time | 0% | -57.9% | -209.85% | 0% |
| Dept financing | 25% | 22% | 16% | 25% |
| Current Ratio | 3.54% | 1.12% | 1.16% | 0.91% |
| Quick Ratio | 0% | 0.86% | 0.92% | 0.8% |
| Cash Position Ratio | 2.35% | 0.12% | 0.51% | 0.36% |
| Liquididy | 50% | 33% | 39% | 32% |